{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T14:35:20Z","timestamp":1792852520514,"version":"4.5.0"},"reference-count":53,"publisher":"Society of Nuclear Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2025,12,30]]},"published-print":{"date-parts":[[2026,4]]},"DOI":"10.2967\/jnumed.125.271317","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T16:00:14Z","timestamp":1769097614000},"page":"548-554","source":"Crossref","is-referenced-by-count":7,"title":["Initial Results and Clinical Experiences of [\n                    <sup>177<\/sup>\n                    Lu]Lu-FAP-2286 for Pleural Metastases: A Single-Center Retrospective Study"],"prefix":"10.2967","volume":"67","author":[{"given":"Linwei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingzhi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2026,1,22]]},"reference":[{"key":"2026040105551074000_67.4.548.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.03.003"},{"key":"2026040105551074000_67.4.548.2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21708"},{"key":"2026040105551074000_67.4.548.3","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1055\/s-2001-18796","article-title":"Malignant pleural effusions","volume":"22","author":"Sahn","year":"2001","journal-title":"Semin Respir Crit Care Med."},{"key":"2026040105551074000_67.4.548.4","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.athoracsur.2018.04.073","article-title":"Pericardial and pleural metastases: clinical, histologic, and molecular differences","volume":"106","author":"Karpathiou","year":"2018","journal-title":"Ann Thorac Surg."},{"key":"2026040105551074000_67.4.548.5","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.01.00225601"},{"key":"2026040105551074000_67.4.548.6","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.oraloncology.2010.06.014","article-title":"Pleural metastases as a unique entity with dismal outcome of head and neck squamous cell carcinoma","volume":"46","author":"Shao","year":"2010","journal-title":"Oral Oncol."},{"key":"2026040105551074000_67.4.548.7","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/RCT.0000000000000528","article-title":"Pleural metastasis in head and neck cancer: imaging findings and clinical impact","volume":"41","author":"Wang","year":"2017","journal-title":"J Comput Assist Tomogr."},{"key":"2026040105551074000_67.4.548.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0720-048X(00)00168-6"},{"key":"2026040105551074000_67.4.548.9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/1759-7714.12412","article-title":"Effect of visceral pleural invasion on the prognosis of patients with lymph node negative non-small cell lung cancer","volume":"8","author":"Tian","year":"2017","journal-title":"Thorac Cancer."},{"key":"2026040105551074000_67.4.548.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2022.04.017"},{"key":"2026040105551074000_67.4.548.11","doi-asserted-by":"publisher","DOI":"10.1378\/chest.117.1.79"},{"key":"2026040105551074000_67.4.548.12","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00349-2018"},{"key":"2026040105551074000_67.4.548.13","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1007\/s00259-024-06635-8","article-title":"[68Ga]Ga-FAP-2286, a novel promising theragnostic approach for PET\/CT imaging in patients with various type of metastatic cancers","volume":"51","author":"Banihashemian","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026040105551074000_67.4.548.14","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-023-06144-0"},{"key":"2026040105551074000_67.4.548.15","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-022-05842-5"},{"key":"2026040105551074000_67.4.548.16","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1007\/s00259-023-06272-7","article-title":"Head-to-head comparison of different classes of FAP radioligands designed to increase tumor residence time: monomer, dimer, albumin binders, and small molecules vs peptides","volume":"50","author":"Millul","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026040105551074000_67.4.548.17","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.259192"},{"key":"2026040105551074000_67.4.548.18","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00259-024-06795-7","article-title":"Feasibility and therapeutic potential of [177Lu]Lu-FAPI-2286 in patients with advanced metastatic sarcoma","volume":"52","author":"Banihashemian","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026040105551074000_67.4.548.19","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1097\/RLU.0000000000005255","article-title":"First experience of radionuclide therapy with 177Lu-FAPI-2286 in a patient with metastatic mediastinal sarcoma","volume":"49","author":"Banihashemian","year":"2024","journal-title":"Clin Nucl Med."},{"key":"2026040105551074000_67.4.548.20","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1007\/s00259-024-06817-4","article-title":"The complete metabolic\/molecular response to chemotherapy combined with [177Lu]Lu-FAP-2286 in metastatic breast cancer","volume":"51","author":"Banihashemian","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026040105551074000_67.4.548.21","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s00259-025-07258-3","article-title":"[177Lu]Lu-FAP-2286 therapy in ovarian neuroendocrine carcinoma: a promising theranostic approach","volume":"53","author":"Alan-Selcuk","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026040105551074000_67.4.548.22","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1007\/s00259-025-07265-4","article-title":"Comparison of the diagnostic value of [68Ga]Ga-FAP-2286 PET\/CT and [18F]-FDG PET\/CT imaging in different types of pleural and peritoneal metastatic tumors","volume":"52","author":"Liu","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026040105551074000_67.4.548.23","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1097\/RLU.0000000000005297","article-title":"Efficacy and safety evaluation of 177Lu-FAP-2286 in the treatment of advanced lung cancer","volume":"49","author":"Xie","year":"2024","journal-title":"Clin Nucl Med."},{"key":"2026040105551074000_67.4.548.24","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1097\/RLU.0000000000005258","article-title":"177Lu-FAP-2286 therapy in a patient with metastatic rhabdoid meningioma","volume":"49","author":"Wan","year":"2024","journal-title":"Clin Nucl Med."},{"key":"2026040105551074000_67.4.548.25","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1097\/RLU.0000000000004865","article-title":"177Lu-FAP-2286 therapy in a case of recurrent bladder cancer with multiple metastatic lesions","volume":"48","author":"Li","year":"2023","journal-title":"Clin Nucl Med."},{"key":"2026040105551074000_67.4.548.26","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1007\/s00259-022-06048-5","article-title":"[177Lu]Lu-FAP-2286 therapy in a case of right lung squamous cell carcinoma with systemic metastases","volume":"50","author":"Rao","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026040105551074000_67.4.548.27","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/RLU.0000000000005169","article-title":"Metastatic lung adenocarcinoma received combined 177Lu-FAP-2286 radiation therapy and targeted therapy","volume":"49","author":"Yang","year":"2024","journal-title":"Clin Nucl Med."},{"key":"2026040105551074000_67.4.548.28","doi-asserted-by":"crossref","unstructured":"Wang K Xu T Mou L Chen Y Huang Z . [177Lu]Lu-FAP-2286 therapy in a case of gastric adenocarcinoma with peritoneal metastasis. September 12, 2025 [Epub ahead of print].","DOI":"10.1007\/s00259-025-07545-z"},{"key":"2026040105551074000_67.4.548.29","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/RLU.0000000000005489","article-title":"177Lu-FAP-2286 therapy in a case of squamous lung cancer","volume":"50","author":"Li","year":"2025","journal-title":"Clin Nucl Med."},{"key":"2026040105551074000_67.4.548.30","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/RLU.0000000000005168","article-title":"177Lu-FAP-2286 therapy in a metastatic bone malignant solitary fibrous tumor","volume":"49","author":"Yang","year":"2024","journal-title":"Clin Nucl Med."},{"key":"2026040105551074000_67.4.548.31","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1148\/radiol.2016142043","article-title":"Practical PERCIST: a simplified guide to PET Response Criteria in Solid Tumors 1.0","volume":"280","author":"O","year":"2016","journal-title":"Radiology."},{"key":"2026040105551074000_67.4.548.32","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.262468"},{"key":"2026040105551074000_67.4.548.33","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.1097\/RLU.0000000000003810","article-title":"Feasibility and therapeutic potential of 177Lufibroblast activation protein inhibitor46 for patients with relapsed or refractory cancers: a preliminary study","volume":"46","author":"Assadi","year":"2021","journal-title":"Clin Nucl Med."},{"key":"2026040105551074000_67.4.548.34","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.268386"},{"key":"2026040105551074000_67.4.548.35","doi-asserted-by":"crossref","first-page":"12745","DOI":"10.1021\/acs.jmedchem.5c00637","article-title":"Rational design and preliminary evaluation of a radiopharmaceutical targeting fibroblast activation proteins [68Ga]Ga\/[177Lu]Lu-FAPI-JNU for tumor imaging and therapy","volume":"68","author":"Luo","year":"2025","journal-title":"J Med Chem."},{"key":"2026040105551074000_67.4.548.36","doi-asserted-by":"crossref","first-page":"109031","DOI":"10.1016\/j.nucmedbio.2025.109031","article-title":"Exploration of the utilization of irreversible cysteine protease inhibitor in FAP-targeted radiopharmaceuticals design to increase tumor residence time","volume":"146-147","author":"Brake","year":"2025","journal-title":"Nucl Med Biol."},{"key":"2026040105551074000_67.4.548.37","doi-asserted-by":"crossref","first-page":"47869","DOI":"10.1021\/acsami.5c07340","article-title":"Theranostic potential of [68Ga]Ga\/[177Lu]Lu-LNC1013: a dual-purpose ligand for cancer imaging and radionuclide therapy","volume":"17","author":"Wang","year":"2025","journal-title":"ACS Appl Mater Interfaces."},{"key":"2026040105551074000_67.4.548.38","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1021\/acs.bioconjchem.5c00369","article-title":"Design, synthesis, and preclinical evaluation of 89Zr\/177Lu-FAPI-Tz: a potential theranostic pair targeting fibroblast activation protein","volume":"36","author":"Ma","year":"2025","journal-title":"Bioconjug Chem."},{"key":"2026040105551074000_67.4.548.39","doi-asserted-by":"crossref","first-page":"17785","DOI":"10.1021\/acs.jmedchem.4c01812","article-title":"68Ga\/177Lu-labeled theranostic pair for targeting fibroblast activation protein with improved tumor uptake and retention","volume":"67","author":"Huang","year":"2024","journal-title":"J Med Chem."},{"key":"2026040105551074000_67.4.548.40","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.268200"},{"key":"2026040105551074000_67.4.548.41","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.268689"},{"key":"2026040105551074000_67.4.548.42","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.1007\/s00259-025-07362-4","article-title":"Pharmacokinetics study of FT-FAPI, a novel multi-nuclide label-able FAP targeting tracer, in mice and healthy volunteers","volume":"52","author":"Ye","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026040105551074000_67.4.548.43","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07461-6"},{"key":"2026040105551074000_67.4.548.44","doi-asserted-by":"crossref","first-page":"4084","DOI":"10.7150\/thno.106108","article-title":"Therapeutic potential of FAPI RLT in oncology: a systematic review","volume":"15","author":"Ruzzeh","year":"2025","journal-title":"Theranostics."},{"key":"2026040105551074000_67.4.548.45","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1158\/1078-0432.CCR-24-3918","article-title":"177Lu-LNC1004 radioligand therapy in patients with end-stage metastatic cancers: a single-center, single-arm, phase II study","volume":"31","author":"Fu","year":"2025","journal-title":"Clin Cancer Res."},{"key":"2026040105551074000_67.4.548.46","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00259-023-06482-z","article-title":"Therapeutic potential of [177Lu]Lu-DOTAGA-FAPi dimers in metastatic breast cancer patients with limited treatment options: efficacy and safety assessment","volume":"51","author":"Yadav","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026040105551074000_67.4.548.47","first-page":"65","article-title":"Novel fibroblast activation protein inhibitor-based targeted theranostics for radioiodine-refractory differentiated thyroid cancer patients: a pilot study","volume":"32","author":"Ballal","year":"2022","journal-title":"Thyroid."},{"key":"2026040105551074000_67.4.548.48","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.265986"},{"key":"2026040105551074000_67.4.548.49","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.122.264871"},{"key":"2026040105551074000_67.4.548.50","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1007\/s00259-025-07271-6","article-title":"[18F]FAPI-04 PET\/CT for pathologic response assessment in pancreatic cancer patients with systemic treatment","volume":"52","author":"Li","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026040105551074000_67.4.548.51","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.267581"},{"key":"2026040105551074000_67.4.548.52","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.266403"},{"key":"2026040105551074000_67.4.548.53","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.269431"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.125.271317","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T20:18:43Z","timestamp":1785269923000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.125.271317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,22]]},"references-count":53,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4,1]]},"published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.2967\/jnumed.125.271317"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.125.271317","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,22]]}}}